Sugi Predict

Sugi Predict / Compounds / SCHEMBL3573801

SCHEMBL3573801

SCHEMBL3573801

COc1ccccc1-c1cn(S(=O)(=O)c2ccc(C)cc2)c2ncc(-c3cc(F)c(N=C=O)c(C(=O)N(C)C)c3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.40
▸ ABL1 P00519 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KMT2A Q03164 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ LMNA P02545 3/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ BRD4 O60885 1/20 0.31
▸ EED O75530 1/20 0.31
▸ PIK3CA P42336 4/20 0.30
▸ HDAC1 Q13547 4/20 0.30
▸ L3MBTL1 Q9Y468 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563287 0.89 PTPN11 (0.43) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3568986 0.88 MAP4K1 (0.44) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3566926 0.88 MAP4K1 (0.45) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3566923 0.87 MAP4K1 (0.42) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3565214 0.84 MAP4K1 (0.40) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL13816796 0.84 MAP4K1 (0.40) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL1516677 0.83 PTPN11 (0.43) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3565148 0.83 MAP4K1 (0.59) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3562857 0.83 MAP4K1 (0.39) PTPN11MAP4K1ABL1MAPTTSHR
SCHEMBL3565147 0.82 MAP4K1 (0.48) PTPN11MAP4K1ABL1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
EP-2134343-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2009-12-23 — — EP disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 — — WO disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS MAP4K2, PDXK, MAP4K1 PTPN11 1303/4885MAP4K1 3/4885ABL1 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.